Literature DB >> 24311775

Sputum microbiota in moderate versus severe patients with COPD.

Antonio Galiana1, Estefania Aguirre1, Juan Carlos Rodriguez2, Alex Mira3, Miguel Santibañez4, Inmaculada Candela5, Juana Llavero6, Pedro Garcinuño7, Francisco López8, Montserrat Ruiz1, Eduardo Garcia-Pachon9, Gloria Royo10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24311775     DOI： 10.1183/09031936.00191513

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  17 in total

Review 1.  Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions.

Authors:  Yvonne J Huang; John R Erb-Downward; Robert P Dickson; Jeffrey L Curtis; Gary B Huffnagle; MeiLan K Han
Journal:  Transl Res       Date:  2016-06-23       Impact factor: 7.012

2.  Oropharyngeal Microbiome in Obstructive Sleep Apnea: Decreased Diversity and Abundance.

Authors:  Wenbo Yang; Liang Shao; Mulalibieke Heizhati; Ting Wu; Xiaoguang Yao; Yingchun Wang; Lei Wang; Nanfang Li
Journal:  J Clin Sleep Med       Date:  2019-11-05       Impact factor: 4.062

Review 3.  The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases.

Authors:  Samuel M Gonçalves; Katrien Lagrou; Cláudio Duarte-Oliveira; Johan A Maertens; Cristina Cunha; Agostinho Carvalho
Journal:  Virulence       Date:  2016-11-07       Impact factor: 5.882

Review 4.  Biomarkers of progression of chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annalicia Vaughan; Annette G Dent; Phoebe E O'Hare; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

5.  Characterization of throat microbial flora in smokers with or without COPD.

Authors:  Wenqi Diao; Ning Shen; Yipeng Du; Ke Qian; Bei He
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-04

6.  The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.

Authors:  Refiloe Masekela; Solize Vosloo; Stephanus N Venter; Wilhelm Z de Beer; Robin J Green
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

7.  Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis.

Authors:  Shoichi Fukui; Shimpei Morimoto; Kunihiro Ichinose; Shota Nakashima; Hiroshi Ishimoto; Atsuko Hara; Tomoyuki Kakugawa; Noriho Sakamoto; Yoshika Tsuji; Toshiyuki Aramaki; Tomohiro Koga; Shin-Ya Kawashiri; Naoki Iwamoto; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Yukitaka Ueki; Shino Suzuki; Hiroshi Mukae; Atsushi Kawakami
Journal:  Sci Rep       Date:  2020-06-11       Impact factor: 4.379

8.  Human Microbe-Disease Association Prediction With Graph Regularized Non-Negative Matrix Factorization.

Authors:  Bin-Sheng He; Li-Hong Peng; Zejun Li
Journal:  Front Microbiol       Date:  2018-11-01       Impact factor: 5.640

9.  Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.

Authors:  David Mayhew; Nathalie Devos; Christophe Lambert; James R Brown; Stuart C Clarke; Viktoriya L Kim; Michal Magid-Slav; Bruce E Miller; Kristoffer K Ostridge; Ruchi Patel; Ganesh Sathe; Daniel F Simola; Karl J Staples; Ruby Sung; Ruth Tal-Singer; Andrew C Tuck; Stephanie Van Horn; Vincent Weynants; Nicholas P Williams; Jeanne-Marie Devaster; Tom M A Wilkinson
Journal:  Thorax       Date:  2018-01-31       Impact factor: 9.139

10.  Microbial and host immune factors as drivers of COPD.

Authors:  Moana Mika; Izabela Nita; Laura Morf; Weihong Qi; Seraina Beyeler; Eric Bernasconi; Benjamin J Marsland; Sebastian R Ott; Christophe von Garnier; Markus Hilty
Journal:  ERJ Open Res       Date:  2018-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.